Fenofibrate improved both HFD-induced insulin resistance in skeletal muscle and palmitic acid-induced insulin resistance in myotube cells, thus reduced ER stress-induced inflammation via inhibiting TLR4/NF-κB pathway [30]. Here, TLR4 is linked to Insulin resistance.